NO20076624L - Syklisk aminderivat med substituert alkylgruppe - Google Patents
Syklisk aminderivat med substituert alkylgruppeInfo
- Publication number
- NO20076624L NO20076624L NO20076624A NO20076624A NO20076624L NO 20076624 L NO20076624 L NO 20076624L NO 20076624 A NO20076624 A NO 20076624A NO 20076624 A NO20076624 A NO 20076624A NO 20076624 L NO20076624 L NO 20076624L
- Authority
- NO
- Norway
- Prior art keywords
- group
- alkyl group
- hydrogen atom
- substituted alkyl
- amine derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Det er beskrevet en forbindelse representert ved generell formel (I), et farmakologisk akseptabelt salt derav eller et prolegemiddel derav: I formelen betegner R1 et hydrogenatom, en eventuelt substituert Ci-C6~alkyl-gruppe, en eventuelt substituert C3-C6-sykloalkylgruppe eller lignende; R2 betegner et hydrogenatom, et halogenatom, en karboksygruppe, en C2-C7-alkoksy-karbonylgruppe, en karbamoylgruppe, en cyanogruppe, en Ci-C6-alkylgruppe, en halogen-Ci-C6-alkylgruppe, en C1-C6-alkylgruppe substituert med en hetero-arylgruppe eller lignende; R3 betegner en substituert Ci-C6-alkylgruppe, en heterosyklylgruppe eller en mono- til pentasubstituert heterosyklylgruppe; X1, X2, X3, X4 og X5 betegner uavhengig et hydrogenatom, et halogenatom, en aminogruppe, en karboksygruppe, en karbamoylgruppe, en cyanogruppe, en nitrogruppe, en Ci-C6-alkylgruppe eller lignende; og n betegner et helt tall på 0-2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005155009 | 2005-05-27 | ||
PCT/JP2006/310556 WO2006126676A1 (ja) | 2005-05-27 | 2006-05-26 | 置換アルキル基を有する環状アミン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20076624L true NO20076624L (no) | 2008-02-26 |
Family
ID=37452098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20076624A NO20076624L (no) | 2005-05-27 | 2007-12-21 | Syklisk aminderivat med substituert alkylgruppe |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1889835A4 (no) |
JP (1) | JPWO2006126676A1 (no) |
KR (1) | KR20080013944A (no) |
CN (1) | CN101233108A (no) |
AU (1) | AU2006250335B2 (no) |
BR (1) | BRPI0610311A2 (no) |
CA (1) | CA2609852A1 (no) |
IL (1) | IL187524A0 (no) |
NO (1) | NO20076624L (no) |
RU (1) | RU2382771C2 (no) |
TW (1) | TW200720252A (no) |
WO (1) | WO2006126676A1 (no) |
ZA (1) | ZA200710172B (no) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007001974A (ja) * | 2005-05-27 | 2007-01-11 | Sankyo Co Ltd | ヘテロアリール環を有する環状アミン誘導体を含有する医薬組成物 |
US9303038B2 (en) | 2011-09-06 | 2016-04-05 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological diseases |
WO2013168021A1 (en) | 2012-05-07 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders |
JP2015519334A (ja) * | 2012-05-07 | 2015-07-09 | セリックスビオ プライヴェート リミテッド | 抗血小板薬のプロドラッグ |
JP2015519333A (ja) | 2012-05-07 | 2015-07-09 | セリックスビオ プライヴェート リミテッド | 神経疾患の治療のための組成物および方法 |
US9522884B2 (en) | 2012-05-08 | 2016-12-20 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic disorders |
US9266823B2 (en) | 2012-05-08 | 2016-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of parkinson's disease |
US9309233B2 (en) | 2012-05-08 | 2016-04-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of blood clotting disorders |
WO2013168022A1 (en) * | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treating atherothrombosis |
WO2013167993A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurological degenerative disorders |
US9403826B2 (en) | 2012-05-08 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory disorders |
US9273061B2 (en) | 2012-05-10 | 2016-03-01 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
WO2013168014A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of familial amyloid polyneuropathy |
US9321775B2 (en) | 2012-05-10 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
US9242939B2 (en) | 2012-05-10 | 2016-01-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
US9499526B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
WO2013168015A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of asthma and allergy |
WO2013167999A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurologic diseases |
WO2013168005A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
US9573927B2 (en) | 2012-05-10 | 2017-02-21 | Cellix Bio Private Limited | Compositions and methods for the treatment of severe pain |
US9315478B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9346742B2 (en) | 2012-05-10 | 2016-05-24 | Cellix Bio Private Limited | Compositions and methods for the treatment of fibromyalgia pain |
WO2013168002A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurological conditions |
SG11201407318UA (en) | 2012-05-10 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of metabolic syndrome |
WO2013175376A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of local pain |
EP2852570B1 (en) | 2012-05-23 | 2020-04-22 | Cellixbio Private Limited | Composition for the treatment of inflammatory bowel disease |
WO2013175344A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
WO2013175347A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of respiratory disorders |
EP2852571A4 (en) | 2012-05-23 | 2015-11-25 | Cellix Bio Private Ltd | COMPOSITIONS AND METHOD FOR THE TREATMENT OF MUCOSITIS |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
US9187427B2 (en) | 2012-08-03 | 2015-11-17 | Cellix Bio Private Limited | N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases |
US9624168B2 (en) | 2012-09-06 | 2017-04-18 | Cellix Bio Private Limited | Compositions and methods for the treatment inflammation and lipid disorders |
WO2014037834A2 (en) | 2012-09-08 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment of inflammation and lipid disorders |
SG11201505283RA (en) * | 2013-01-09 | 2015-08-28 | Univ Michigan | Mixed disulfide conjugates of thienopyridine compounds and uses thereof |
US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
WO2014195961A1 (en) | 2013-06-04 | 2014-12-11 | Mahesh Kandula | Compositions and methods for the treatment of diabetes and pre-diabetes |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
WO2016046835A1 (en) | 2014-09-26 | 2016-03-31 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
JP6698643B2 (ja) | 2014-09-29 | 2020-05-27 | セリックス バイオ プライヴェート リミテッドCellix Bio Private Limited | 多発性硬化症の治療のための組成物及び方法 |
AU2014414316B2 (en) | 2014-10-27 | 2020-04-09 | Cellix Bio Private Limited | Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis |
US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
JP6679616B2 (ja) | 2015-01-06 | 2020-04-22 | セリックス バイオ プライヴェート リミテッドCellix Bio Private Limited | 炎症及び疼痛の治療のための組成物及び方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3274088B2 (ja) * | 1996-08-28 | 2002-04-15 | 三共株式会社 | 環状アミン誘導体 |
NZ334389A (en) * | 1996-08-28 | 2001-05-25 | Ube Industries | Cyclic amine derivatives |
JP3856185B2 (ja) * | 1998-02-27 | 2006-12-13 | 三共株式会社 | 環状アミノ化合物 |
DK1063230T3 (da) * | 1998-02-27 | 2003-07-14 | Sankyo Co | Cykliske aminoforbindelser |
JP3907029B2 (ja) * | 1998-02-27 | 2007-04-18 | 三共株式会社 | 環状アミン誘導体を含有する医薬 |
MXPA06006035A (es) * | 2003-11-28 | 2007-01-26 | Sankyo Co | Derivado de amina ciclica que tiene un anillo heteroarilo. |
-
2006
- 2006-05-26 EP EP06746885A patent/EP1889835A4/en not_active Withdrawn
- 2006-05-26 RU RU2007149317/04A patent/RU2382771C2/ru not_active IP Right Cessation
- 2006-05-26 TW TW095118701A patent/TW200720252A/zh unknown
- 2006-05-26 WO PCT/JP2006/310556 patent/WO2006126676A1/ja active Application Filing
- 2006-05-26 KR KR1020077027576A patent/KR20080013944A/ko not_active Application Discontinuation
- 2006-05-26 CN CNA2006800275417A patent/CN101233108A/zh active Pending
- 2006-05-26 CA CA002609852A patent/CA2609852A1/en not_active Abandoned
- 2006-05-26 JP JP2007517917A patent/JPWO2006126676A1/ja not_active Withdrawn
- 2006-05-26 AU AU2006250335A patent/AU2006250335B2/en not_active Expired - Fee Related
- 2006-05-26 BR BRPI0610311-1A patent/BRPI0610311A2/pt not_active IP Right Cessation
-
2007
- 2007-11-20 IL IL187524A patent/IL187524A0/en unknown
- 2007-11-26 ZA ZA200710172A patent/ZA200710172B/xx unknown
- 2007-12-21 NO NO20076624A patent/NO20076624L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1889835A1 (en) | 2008-02-20 |
JPWO2006126676A1 (ja) | 2008-12-25 |
ZA200710172B (en) | 2008-11-26 |
CA2609852A1 (en) | 2006-11-30 |
WO2006126676A1 (ja) | 2006-11-30 |
EP1889835A4 (en) | 2010-04-28 |
RU2007149317A (ru) | 2009-07-10 |
RU2382771C2 (ru) | 2010-02-27 |
AU2006250335B2 (en) | 2010-09-02 |
KR20080013944A (ko) | 2008-02-13 |
AU2006250335A1 (en) | 2006-11-30 |
BRPI0610311A2 (pt) | 2010-06-15 |
TW200720252A (en) | 2007-06-01 |
CN101233108A (zh) | 2008-07-30 |
IL187524A0 (en) | 2008-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20076624L (no) | Syklisk aminderivat med substituert alkylgruppe | |
NO20073663L (no) | Tiazol-4-karboksamid-derivater som mGluR5 antagonister | |
NO20092770L (no) | Nye aminopyrimidinderivater som PLK1-inhibitorer | |
NO20060142L (no) | Syklisk tertiaer aminforbindelse | |
NO20084456L (no) | Organiske forbindelser | |
NO20084302L (no) | 2-(syklisk amino)-pyrimidonderivater som TPK1-inhibitorer | |
NO20083582L (no) | Pyridin-2-karboksamide derivater | |
RS53839B1 (en) | SPIROCYCLES AS INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1 | |
NO341631B1 (no) | Hydroksybenzamidderivater og deres anvendelse, fremgangsmåte for fremstilling og farmasøytiske sammensetninger | |
ATE553106T1 (de) | Heteroarylpyrrolopyridinone als kinaseinhibitoren | |
CY1112006T1 (el) | Μακροκυκλικοι αναστολεις του ιου της ηπατιτιδας c | |
EA200801381A1 (ru) | Производные пиримидина | |
NO20082388L (no) | Heteroaryl substituerte piperidinderivater som L-CPT1 inhibitorer | |
TN2010000091A1 (en) | Substituted pyrazole derivative | |
MX2008014908A (es) | Compuesto heterociclico nuevo o sal del mismo e intermedio del mismo. | |
NO20091553L (no) | Fenylderivater og deres anvendelse som immunmodulatorer | |
NO20064077L (no) | Kemokinreseptorantagonister | |
EA201000413A1 (ru) | Способ получения производных лактамида, новые производные лактамида и препараты, содержащие производные лактамида | |
ATE431333T1 (de) | Amino-propanolderivate | |
MX2010008361A (es) | Derivados de arilamida oxazepinopirimidona sustituidos. | |
NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
TW200609220A (en) | Tetrahydroisoquinolylsulphonamide derivatives, their preparation and their use in therapeutics | |
MX2009007954A (es) | Derivado de heterocicliden-n-(aril) acetamida. | |
MX2010008360A (es) | Derivados de oxazepinopirimidona heteroarilamida sustituidos. | |
WO2008136444A1 (ja) | 縮合複素環誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |